Global Nitric Oxide Therapy System Market Size, by Type (Portable, Fixed), by Application (Erectile Dysfunction, Muscle Soreness), by End User (Hospitals, Homecare Settings) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1071378
  • |
  • Date : June 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Nitric Oxide Therapy System Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Increasing prevalence of diabetes and improper nitric oxide production by body are increasing the market growth. However. Limitations associated with the system might restraint the market growth.

The global nitric oxide therapy system market is primarily segmented based on type, application, end user and regions.

On the basis of type, the market is split into:
* Portable
* Fixed

On the basis of application, the market is split into:
* Erectile Dysfunction
* Muscle Soreness
* Blood Pressure
* Diabetes

On the basis of end user, the market is split into:
* Hospitals
* Homecare Settings
* Other End User

Moreover, the market is classified based on region and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* BOC Healthcare
* Dan Hammer Health LTD
* Eku Elektronik GmbH
* GeNO LLC
* International Biomedical
* SLE Ltd
* Mallinckrodt
* Praxair, Inc.
* Vapotherm Inc.
* Bellerophon Therapeutics

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, type, application, end user and market size and their forecast from 2015-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions type, application, end user and options with qualitative and quantitative information and facts

Target Audience:
* Nitric Oxide Therapy System Providers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Therapy System Providers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Nitric Oxide Therapy System Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Nitric Oxide Therapy System Market - Porter\'s Five Forces Analysis
4.4. Global Nitric Oxide Therapy System Market - PESTEL Analysis

5. Global Nitric Oxide Therapy System Market, by Type
5.1. Global Nitric Oxide Therapy System Market, Size and Forecast, 2015-2026
5.2. Global Nitric Oxide Therapy System Market by Portable, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Nitric Oxide Therapy System Market by Fixed, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026

6. Global Nitric Oxide Therapy System Market, by Application
6.1. Global Nitric Oxide Therapy System Market, Size and Forecast, 2015-2026
6.2. Global Nitric Oxide Therapy System Market by Erectile Dysfunction, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Nitric Oxide Therapy System Market by Muscle Soreness, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Nitric Oxide Therapy System Market by Blood Pressure, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Nitric Oxide Therapy System Market by Diabetes, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026

7. Global Nitric Oxide Therapy System Market, by End User
7.1. Global Nitric Oxide Therapy System Market, Size and Forecast, 2015-2026
7.2. Global Nitric Oxide Therapy System Market by Hospitals, 2015-2026
7.2.1. Key driving factors, trends and opportunities
7.2.2. Market size and forecast, 2015-2026
7.3. Global Nitric Oxide Therapy System Market by Homecare Settings, 2015-2026
7.3.1. Key driving factors, trends and opportunities
7.3.2. Market size and forecast, 2015-2026
7.4. Global Nitric Oxide Therapy System Market by Other End Users, 2015-2026
7.4.1. Key driving factors, trends and opportunities
7.4.2. Market size and forecast, 2015-2026

8. Global Nitric Oxide Therapy System Market by Region
8.1. Nitric Oxide Therapy System Market Regional Analysis, 2015-2026
8.2. Global Nitric Oxide Therapy System Market Revenue (USD Million) by Region, 2015-2026
8.3. North America Nitric Oxide Therapy System Market, 2015-2026
8.3.1. North America Nitric Oxide Therapy System Market Size and Forecast, 2015-2026
8.3.2. North America Nitric Oxide Therapy System Market by Country, 2015-2026
8.3.2.1. U.S. Nitric Oxide Therapy System Market, 2015-2026
8.3.2.2. Canada Nitric Oxide Therapy System Market, 2015-2026
8.4. Europe Nitric Oxide Therapy System Market, 2015-2026
8.4.1. Europe Nitric Oxide Therapy System Market Size and Forecast, 2015-2026
8.4.2. Europe Nitric Oxide Therapy System Market by Country, 2015-2026
8.4.2.1. Germany Nitric Oxide Therapy System Market, 2015-2026
8.4.2.2. France Nitric Oxide Therapy System Market, 2015-2026
8.4.2.3. Italy Nitric Oxide Therapy System Market, 2015-2026
8.4.2.4. UK Nitric Oxide Therapy System Market, 2015-2026
8.4.2.5. Spain Nitric Oxide Therapy System Market, 2015-2026
8.4.2.6. Rest of Europe Nitric Oxide Therapy System Market, 2015-2026
8.5. Asia Pacific Nitric Oxide Therapy System Market, 2015-2026
8.5.1. Asia Pacific Nitric Oxide Therapy System Market Size and Forecast, 2015-2026
8.5.2. Asia Pacific Nitric Oxide Therapy System Market by Country, 2015-2026
8.5.2.1. Japan Nitric Oxide Therapy System Market, 2015-2026
8.5.2.2. China Nitric Oxide Therapy System Market, 2015-2026
8.5.2.3. India Nitric Oxide Therapy System Market, 2015-2026
8.5.2.4. Rest of Asia Pacific Nitric Oxide Therapy System Market, 2015-2026
8.6. South America Nitric Oxide Therapy System Market, 2015-2026
8.6.1. South America Nitric Oxide Therapy System Market Size and Forecast, 2015-2026
8.6.2. South America Nitric Oxide Therapy System Market by Country, 2015-2026
8.6.2.1. Mexico Nitric Oxide Therapy System Market, 2015-2026
8.6.2.2. Brazil Nitric Oxide Therapy System Market, 2015-2026
8.6.2.3. Rest of South America Nitric Oxide Therapy System Market, 2015-2026
8.7. Middle East & Africa Nitric Oxide Therapy System Market, 2015-2026
8.7.1. Middle East & Africa Nitric Oxide Therapy System Market Size and Forecast, 2015-2026
8.7.2. Middle East & Africa Nitric Oxide Therapy System Market by Country, 2015-2026
8.7.2.1. Saudi Arabia Nitric Oxide Therapy System Market, 2015-2026
8.7.2.2. South Africa Nitric Oxide Therapy System Market, 2015-2026
8.7.2.3. Rest of Middle East & Africa Nitric Oxide Therapy System Market, 2015-2026

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis/Top Player Positioning, 2018

10. Company Profiles
10.1. BOC Healthcare
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Benchmarking
10.1.4. Key Developments
10.2. Dan Hammer Health LTD
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Benchmarking
10.2.4. Key Developments
10.3. Eku Elektronik GmbH
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Benchmarking
10.3.4. Key Developments
10.4. GeNO LLC
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Benchmarking
10.4.4. Key Developments
10.5. International Biomedical
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Benchmarking
10.5.4. Key Developments
10.6. SLE Ltd
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Benchmarking
10.6.4. Key Developments
10.7. Mallinckrodt
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Benchmarking
10.7.4. Key Developments
10.8. Praxair, Inc.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Benchmarking
10.8.4. Key Developments
10.9. Vapotherm Inc.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Benchmarking
10.9.4. Key Developments
10.10. Bellerophon Therapeutics
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Product Benchmarking
10.10.4. Key Developments

11. Key Insights

Content are not available

Choose License Type